跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nabota - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nabota
Approved
STANDARD
Nabota
Daewoong Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
78526a2cf9492621
Company
Daewoong Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
78526a2cf9492621
Drug Approval Philippines Name
Nabota
Product Name
Nabota
Registration Number
BRP-072
Brand Name
Nabota
Generic Name
Botulinum Toxin Type A (from clostridium botulinum)
Dosage Form
Lyophilized Powder For Injection (IM/SC)
Dosage Strength
50 units
Manufacturer
Daewoong Pharmaceutical Co., Ltd.
Importer
Daewoong Pharma Philippines,Inc.
Distributor
Daewoong Pharma Philippines,Inc.
Company Detail Path
/organization/daewoong-pharmaceutical-co-ltd
Issuance Date
29 July 2022
Expiry Date
17 August 2027
Pharmacologic Category
Muscle Relaxant
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
78526a2cf9492621
Type
Standard
Back to Philippines FDA Approvals